Private Advisor Group, LLC Adial Pharmaceuticals, Inc. Transaction History

Private Advisor Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 13, 2022	SELL	$28.0 - $53.25 $357,000 - $678,937	-12,750 Reduced 37.34%	21,400 $29,000
Q4 2021 Feb 10, 2022	SELL	$62.25 - $104.5 $77,812 - $130,625	-1,250 Reduced 3.53%	34,150 $92,000
Q3 2021 Oct 14, 2021	SELL	$57.75 - $116.75 $72,187 - $145,937	-1,250 Reduced 3.41%	35,400 $152,000
Q1 2021 Apr 22, 2021	BUY	$43.25 - $79.75 $1.59 Million - $2.92 Million	36,650 New	36,650 $89,000

5.5K

Ticker ADIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,854,000
Market Cap $26M
Description
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focu...

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Advisor Group, LLC with notifications on news.